JFIFC    $ &%# #"(-90(*6+"#2D26;=@@@&0FKE>J9?@=C  =)#)==================================================q" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?!~ S9 p=BSjI̹irnj#DJ4je?r{i|v֏ǥ/Sq@\Gȵe$r<ȈT>g5 :b or^[8hW#hiλ FBEZٌO9@pL(MCZG. C: SRNǟ" Hf>jZJ] | 2Kx$ܟ1H.9Y'Gg I/] E̐x˚;0GpJ+;1çR؈=Rb>JdF}hunA@HT[*"\#,pD~~O? Ri;"+߅4܏ɞN)s,=괓ۡ9Zjt7?ʕ ZW PI@_>CbqA97*IqHöW֡2=0=E/ǀ?*(X6jcŪʮ{YЭΣ0]Ḋ?LVcm7SvaȐ E>f;mϠ`%6qeQݯVvQK YAc+֋u4P/S֑ L?$S"{h% y0m8=~IXgU!G+ {$`)4滸&ٴ󦤂}6?y20p4<2屑81hI,<'*8۟Ɲ<"+ە'A$Sk)/FϘ܏³w+CB{7Ӯ$~oSViXG/ >ڤghhIj^piGi \fO& ??.6,~b IQՌw>)UW?( {ٙ%paxvrۆAV擸쇬i꼋v 憡{7ų&6j-ͮ.!1GV5;%R^;)4W,Lp}O%ƖNYѿªg u!rOZ.5:Dl$7=*5B o$UamxcRQ%\>]{x]93 ƴٍ"y,KHWYi";-.b""L2㡡+va{|Q!&%$sߐ+nʹ[m#qh4F%Msm#j_=vING)G_g$ B eGZk|]q"QOθ5|'i \zUk>p$cE e{p &˺p?ShH:Q\"bT+|AYKsd )puG+oWC _ R)5d4:M6!$ #]=pk,hpmiӱ  ٸH+k)5 r{U6d l!Ie_# Yy{eF ]R~rH m2rz&dSKEU$ۀh\\8̑eʡ L57,)qmn"H|^>^L08} 57}WAEjU]?u(eKXCd㎆[R81r":rY/k$.ڴ"̟V"@l(qJ*]OH9BMtooC3v_j>mZSjGvX\Gn, Y,OrIeOM7fkCv,H=8De>VL 犹{5i,0K%PĿzv9iR7XKzK++| FOA.d4˝y|rHs$2x `6^W0s}"$qJAݻis2Nq.6CB(.[k(cH7N{\jK+MKފ\sXB s}jݖ>B,P 2) GHjsU4]VY%?4~-6~-omuJ=:qұ18t%\byblbIa(\GTGGvڕ$m*Ʊ% HnXG8(IQJ, #֗map#nFGj=Bk\c_ROj]b)|1H̡4$8c"Vd$netKWݐ0?~92+0߀N3NGvVx*9ϯa&gh X}*]J|yLW1cPH FW`:tRe(ZД5\H[jb/fTwqڭ;0[\ǽDr{q1Eb͖sKV^v5kp\Ǐ~TehD1.>pOOLcj12D?OA4#c{Qp5n+BB;2_\u;=* .ZiUC1g_΋.#B0۲i3FxeD^v=p=h7[Vu gz*5R3}z}j0$aKr)IphVl ΅-x2 *ӟ±5_.Kk>~0]-H!F=ݓU~Vh> w`Ւ)xvLP&%;ڳ+ku9Hrʣ𴒥ʹ7';ГP)$ή3K=ĥw&wvD:?/>UrVæUn)#QL^{K) :WƘz~4QACN~(KxQE5g\zoʊ) g_?nIMR{;Q@BMn? !e* ٴg EF죌~Ac;?/^{y+<*|Cw Ufn5#hdP$v=&w*iv`~j~n؜dV[( +BCƳL` sYf1Z߀;|'rF0?*j @ב˵B2':89[R\8g91 Z#ި"HܫiXw&yeagBɌ4+g2]0lJzy7gxJ~`Xt%|1ʅHםh%^s3idOq.6/7g؎t8;{Zxȷ[7ӓ[$L8 (uJ)ƚ=ZҠ}޵3^S rNe;? nOa_^X2`89\cTl`ʳr74 1=C2Hb+X9deEEs_)bHr3W=}SU[+0 f·uhց+Z ?:,bFZ>wZ¿rra|60èݓ>8ʊpQѵ-&K]pٸI=y&ҫX+V%` m|IsO(*p2g$~ ^lvP=qg?)I#}y=pM Dͤ|TU_V ?L |'.%+ SZKM5?j#_hϲ?]_& Gob槏Öse8ɢwTvFNξmbRFERӵ K}>e1*UcoLU?TH{+4@c( TM9AmqҐkv hP4=\AS"sYCo}{L.#?JP;ST)c?l~6D=€5@'=Lb?#o?S'?5C?EY 3tE|KE$ EV? 8>SX[!iqҳWz6ܝB:w QjPg .ƑbLtgCʨgQ R:McQbt)HT4NڌSO4@ru+|v'6 qA C PRhlj0c _Ps?/+RYk{zޗy\CkyMO=1K;Tɍ#Tnb>l.}ɢ vYF$,BGD |FIȩ.]Juŷ;@X[UP2#2ݰ#$?ҳ/Ǖ:5̊8OX"H38F`Wg$uO9Ä^p35o*5qf0 z9-'yB:VEuf,r; v0PAu epwkf9'A֐Dn:u*i,YFF{6 fRq{qM27Q "\U.}$ >k3 ҔY{V$S2ڶ4r@JHT sjA!@sמإ6,I#C|SOc;?O01IF:sVypx/LzUcPOggȿ"77&JE*ǒ3 p}h#he liver and kidneys? This has been and is currently being studied by three well known and highly respected researchers, Dr. Bill Kraemer, Dr. Rick Kreider, and Mr. Mike Stone to date, no undesirable side effects have been found. Kreider studied the effects of creatine on college football players and reported "no impact on tests of liver or kidney function." Kraemer examined active college students at Penn State after a heavy work out. He also found no side effects from the use of creatine. He examined hormone levels, blood profiles and muscle biopsies. Participants also filled out questionnaires regarding any side effects such as cramping, diarrhea, nausea. None were reported. Not only has Kraemer thoroughly examined creatine, he also used it when he was a competitive athlete as did his 17-year-old daughter when she played high school tennis and his 15-year-ld son when he was weight lifting. Again, no adverse side affects. Creatine does have one well-documented side effect. It causes an increase in muscle mass. When taken as prescribed it has the capacity to increase body weight by as much as seven pounds in five days.<br>Are there any long term effects? The long term effect of creatine has never been studi